Natco Pharma Limited (NATCOPHARM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.138x

Based on the latest financial reports, Natco Pharma Limited (NATCOPHARM) has a cash flow conversion efficiency ratio of 0.138x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs11.91 Billion ≈ $128.76 Million USD) by net assets (Rs86.54 Billion ≈ $935.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Natco Pharma Limited balance sheet quality to measure how much of total assets are equity-financed.

Natco Pharma Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Natco Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check NATCOPHARM cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Natco Pharma Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Natco Pharma Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Jeudan
CO:JDAN
0.023x
Stolt-Nielsen Limited
OL:SNI
0.060x
Punjab & Sind Bank
NSE:PSB
-0.594x
Gansu Qilianshan Cement Group Co Ltd
SHG:600720
0.016x
ANI Pharmaceuticals Inc
NASDAQ:ANIP
0.056x
Luoyang Xinqianglian Slewing Bearin
SHE:300850
-0.002x
Gorman-Rupp Company
NYSE:GRC
0.036x
Spectrum Brands Holdings Inc
NYSE:SPB
0.035x

Annual Cash Flow Conversion Efficiency for Natco Pharma Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Natco Pharma Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Natco Pharma Limited market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs76.12 Billion
≈ $823.24 Million
Rs16.97 Billion
≈ $183.50 Million
0.223x +4.18%
2024-03-31 Rs58.53 Billion
≈ $632.99 Million
Rs12.52 Billion
≈ $135.43 Million
0.214x +130.24%
2023-03-31 Rs91.37 Billion
≈ $988.18 Million
Rs8.49 Billion
≈ $91.83 Million
0.093x +752.04%
2022-03-31 Rs42.64 Billion
≈ $461.09 Million
Rs465.00 Million
≈ $5.03 Million
0.011x -84.95%
2021-03-31 Rs41.23 Billion
≈ $445.93 Million
Rs2.99 Billion
≈ $32.31 Million
0.072x -34.28%
2020-03-31 Rs37.85 Billion
≈ $409.30 Million
Rs4.17 Billion
≈ $45.13 Million
0.110x -42.45%
2019-03-31 Rs34.91 Billion
≈ $377.54 Million
Rs6.69 Billion
≈ $72.33 Million
0.192x +27.11%
2018-03-31 Rs30.76 Billion
≈ $332.66 Million
Rs4.64 Billion
≈ $50.14 Million
0.151x -27.94%
2017-03-31 Rs16.53 Billion
≈ $178.81 Million
Rs3.46 Billion
≈ $37.40 Million
0.209x +166.23%
2016-03-31 Rs13.03 Billion
≈ $140.94 Million
Rs1.02 Billion
≈ $11.07 Million
0.079x -27.85%
2015-03-31 Rs8.51 Billion
≈ $92.04 Million
Rs926.66 Million
≈ $10.02 Million
0.109x -44.61%
2014-03-31 Rs7.33 Billion
≈ $79.24 Million
Rs1.44 Billion
≈ $15.58 Million
0.197x +74.77%
2013-03-31 Rs5.44 Billion
≈ $58.84 Million
Rs611.95 Million
≈ $6.62 Million
0.112x -18.24%
2012-03-31 Rs4.72 Billion
≈ $51.05 Million
Rs649.41 Million
≈ $7.02 Million
0.138x -28.06%
2011-03-31 Rs3.53 Billion
≈ $38.23 Million
Rs675.97 Million
≈ $7.31 Million
0.191x -23.21%
2010-03-31 Rs3.11 Billion
≈ $33.60 Million
Rs773.69 Million
≈ $8.37 Million
0.249x +77.24%
2009-03-31 Rs2.66 Billion
≈ $28.77 Million
Rs373.85 Million
≈ $4.04 Million
0.141x -34.64%
2008-03-31 Rs2.25 Billion
≈ $24.34 Million
Rs483.90 Million
≈ $5.23 Million
0.215x -11.13%
2007-03-31 Rs1.86 Billion
≈ $20.12 Million
Rs450.03 Million
≈ $4.87 Million
0.242x +19.35%
2006-03-31 Rs1.54 Billion
≈ $16.64 Million
Rs311.81 Million
≈ $3.37 Million
0.203x -52.96%
2005-03-31 Rs1.14 Billion
≈ $12.29 Million
Rs489.69 Million
≈ $5.30 Million
0.431x --

About Natco Pharma Limited

NSE:NATCOPHARM India Drug Manufacturers - Specialty & Generic
Market Cap
$1.78 Billion
Rs164.24 Billion INR
Market Cap Rank
#6473 Global
#306 in India
Share Price
Rs917.00
Change (1 day)
-1.38%
52-Week Range
Rs792.95 - Rs1206.00
All Time High
Rs1591.09
About

NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; a… Read more